15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $7M | -$45M | 23.4% | -174.6% | -11058.0% | -535.7% | — | $0 | $1M |
| 2024 | $35M | -$168000 | 37.1% | -17.1% | 0.3% | -1.1% | -$4M | $2M | $3M |
| 2024 | — | -$43M | — | — | 78.1% | -127.5% | — | $36M | $106000 |
| 2023 | $39M | -$23M | 30.6% | -54.9% | -772.7% | -136.0% | $79000 | $5M | $4M |
| 2022 | $55M | -$39M | 27.9% | -71.0% | -182.6% | -101.7% | -$21M | $12M | $3M |
| 2021 | $46M | $3M | 33.4% | -37.6% | 5.9% | 4.5% | -$12M | $10M | $22M |
| 2020 | $43M | -$59M | 37.8% | -64.2% | 211.1% | -115.8% | -$8M | $33M | $4M |
| 2019 | $16M | -$184M | 37.6% | -233.2% | 2608.7% | -344.6% | -$21M | $37M | $2M |
| 2018 | $15M | -$6M | 49.3% | -34.9% | 198.1% | -100.7% | -$7M | $6M | $4M |
| 2018 | — | -$3M | — | — | 111.4% | -1411.4% | — | $1M | $199674 |
| 2017 | — | -$2M | — | — | 147.4% | -10679.1% | — | $553977 | $1442 |
| 2016 | — | -$933761 | — | — | 162.6% | -5611.5% | — | — | $10197 |
| 2015 | — | -$49669 | — | — | 2.1% | -2268.0% | — | — | $0 |
| 2015 | — | -$407289 | — | — | 880.2% | -12402.2% | — | — | $0 |
| 2014 | — | -$388541 | — | — | 1101.4% | -7287.0% | — | — | $0 |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $3M | -$4M | 26.7% | -94.4% | -2.9% | -2.8% | — | $0 | $35M |
| Mar '26 | $3M | -$6M | 37.1% | -52.9% | -34.9% | -14.7% | — | $0 | $21M |
| Dec '25 | $3M | -$9M | 37.5% | -135.0% | -244.4% | -31.8% | — | — | $13M |
| Sep '25 | -$35M | -$15M | 25.4% | -60.1% | -3749.6% | -181.6% | — | $0 | $1M |
| Jun '25 | $3M | -$15M | 1.2% | -322.0% | 33.0% | -44.5% | — | $31M | $912000 |
| Mar '25 | $7M | -$10M | 33.3% | -15.2% | 17.3% | -66.4% | -$1M | — | $1M |
| Dec '24 | $7M | -$4M | 36.4% | -23.0% | 6.3% | -25.2% | $1M | $2M | $3M |
| Sep '24 | $11M | -$32M | 39.7% | -9.9% | 58.0% | -94.7% | — | $36M | $106000 |
| Jun '24 | $43M | -$3M | 22.1% | -3.1% | 14.4% | -23.8% | — | — | $3M |
| Mar '24 | $8M | -$3M | 33.1% | -31.2% | -258.9% | -18.3% | -$1M | $5M | $4M |
| Dec '23 | $6M | -$15M | 9.3% | -223.1% | -498.8% | -87.8% | $983000 | $5M | $4M |
| Sep '23 | $13M | -$2M | 33.8% | -19.9% | 4.8% | -5.2% | $343000 | $5M | $4M |
| Jun '23 | $11M | -$3M | 34.1% | -24.5% | -18.3% | -9.7% | $236000 | $3M | $4M |
| Mar '23 | $9M | -$3M | 35.1% | -35.2% | -18.4% | -9.9% | -$1M | $12M | $2M |
| Dec '22 | $9M | -$24M | 17.9% | -260.7% | -113.2% | -63.0% | -$3M | $12M | $3M |
| Sep '22 | $12M | -$7M | 35.1% | -54.0% | -14.4% | -10.1% | -$5M | $12M | $6M |
| Jun '22 | $17M | -$4M | 28.6% | -25.8% | -8.5% | -6.2% | -$5M | $12M | $11M |
| Mar '22 | $17M | -$4M | 27.7% | -23.3% | -7.4% | -5.4% | -$8M | $13M | $16M |
| Dec '21 | $11M | -$5M | 25.1% | -45.3% | -8.8% | -6.8% | -$4M | $10M | $22M |
| Sep '21 | $13M | -$3M | 33.6% | -30.1% | -5.5% | -4.4% | -$4M | $10M | $26M |
How the market has priced SRXH against its own fundamentals since 2025-04 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, SRx Health Solutions, Inc.'s revenue has declined 31.3% per year. These are computed facts, not advice.
As of FY2025, SRx Health Solutions, Inc. reported $0 of total debt against $1M of cash; operating income covered interest expense -18.2×.
In FY2025, gross margin was 23.4%, operating margin -174.6%, and net margin -688.8%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.